All.Can Switzerland welcomes new Member

All.Can Switzerland is pleased to welcome Novartis Switzerland as a new member of All.Can Switzerland this year.

The oncology unit Novartis Oncology will contribute its expertise and network from the field of cancer treatments in the future to achieve the goals of All.Can Switzerland: improving patient benefit and promoting sustainable cancer care in Switzerland.

Posted on:

Related reading

All.Can Argentina activities declared of “Health Interest”

On December 2022, All.Can Argentina activities were declared of “Health interest” by the Buenos Aires City Parliament. The declaration states “The activities carried out by the All.Can Argentina platform which have been carried out from 2019 to the present, are declared to be of Health…

Read more

New All.Can Argentina survey “General Wellbeing of cancer patients”.

All.Can Argentina ended its second survey around cancer patient’s general wellbeing inspired in the PaRIS questionnaire used by the OECD. Carried out together with IPSOS Healthcare, it was a quali-quantitative survey that included 328 patients with cancer (with different types and stages) who have been…

Read more

Lung Cancer screening

As part of its oncology training program, All.Can Argentina produced a new video of lungcancer with focus in the importance of a screening program. The video includesthe participation of physicians from three different areas: Oncology,Pneumonology and Radiology. Throughout the video, the specialists explain riskfactors, symptoms…

Read more